COVID-19 Vaccine Attitude Scale (COVID-19 VAS)
Description
The data for the development and standardization of the "COVID-19 Vaccine Attitude Scale (COVID-19 VAS)" questionnaire are presented in English ("COVID-19 Vaccine Attitude Scale (Eng).xlsx") and in Russian ("COVID-19 Vaccine Attitude Scale (Rus).xlsx"). The study sample includes N = 1965 undergraduate, specialist and master students, of which N = 1592 (81%) women and N = 373 (19%) men aged 16 to 60 years, mean age M = 24.7, SD = 8.4, Me = 21.0. Study was conducted in Moscow State University of Psychology & Education (MSUPE). The questionnaire structure includes 5 scales identified by the method of exploratory factor analysis: Scale 1 "The benefits of vaccination against COVID-19 for an individual and society", Scale 2 "Fear of incidental effects of vaccination against COVID-19 and distrust of information about the vaccination safety", Scale 3 “Denial of the danger of coronavirus and hope for natural immunity”, Scale 4 “Confidence in the serious negative consequences of the coronavirus vaccine” and Scale 5 “Disbelief in the proven international level effectiveness of Russian vaccines”. The construct validity of the questionnaire was statistically proven. Confirmatory factor analysis verified satisfactory goodness-of-fit between the empirical data and the questionnaire structure. The scales correlate with each other moderate, the relationship directions correspond to the expected ones. The high internal reliability of all scales was statistically confirmed using Cronbach's alpha. Satisfactory convergent validity of the corresponding scales of the “COVID-19 Vaccine Attitude Scale (COVID-19 VAS)” with natural science literacy, intelligence and fear of COVID-19 disease was confirmed. All correlations are weak, but theoretically expected and explainable. Statistically proven differential validity. Stanines are calculated. The COVID-19 VAS can be recommended to prepare, conduct and evaluate the effectiveness of educational activities on vaccine prevention against COVID-19 among university students